Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Influence of sleeve gastrectomy on NASH and type 2 diabetes mellitus
Journal of Obesity, Volume 2011, Article 765473, Year 2011
Notification
URL copied to clipboard!
Description
Background. Nonalcoholic fatty liver disease is present in up to 85% of adipose patients and may proceed to nonalcoholic steatohepatitis (NASH). With insulin resistance and obesity being the main risk factors for NASH, the effect of isolated sleeve gastrectomy (ISG) on these parameters was examined. Methods. 236 patients underwent ISG with intraoperative liver biopsy from December 2002 to September 2009. Besides demographic data, pre-operative weight/BMI, HbA1c, AST, ALT, triglycerides, HDL and LDL levels were determined. Results. A significant correlation of NASH with higher HbA1c, AST and ALT and lower levels for HDL was observed (P <. 05, <.0001, <.0001, <.01, resp.). Overall BMI decreased from 45.0 ± 6.8 to 29.7 ± 6.5 and 31.6 ± 4.4 kg/m2 at 1 and 3 years. An impaired weight loss was demonstrated for patients with NASH and patients with elevated HbA1c (plateau 28.08 kg/m 2 versus 29.79 kg/m2 and 32.30 kg/m2 versus 28.79 kg/m2, resp.). Regarding NASH, a significant improvement of AST, ALT, triglyceride and HDL levels was shown (P <. 0001 for all). A resolution of elevated HbA1c was observed in 21 of 23 patients. Summary. NASH patients showed a significant loss of body weight and amelioration of NASH status. ISG can be successfully performed in these patients and should be recommended for this subgroup. © 2011 W. K. Karcz et al.
Authors & Co-Authors
Karcz, W. K.
Germany, Freiburg Im Breisgau
Universität Freiburg
Krawczykowski, D.
Unknown Affiliation
Kuesters, S.
Germany, Freiburg Im Breisgau
Universität Freiburg
Marjanovic, G.
Germany, Freiburg Im Breisgau
Universität Freiburg
Kulemann, B.
Germany, Freiburg Im Breisgau
Universität Freiburg
Grobe, H.
Germany, Freiburg Im Breisgau
Universität Freiburg
Karcz-Socha, Iwona
Poland, Katowice
Slaski Uniwersytet Medyczny w Katowicach
Hopt, U. T.
Germany, Freiburg Im Breisgau
Universität Freiburg
Bukhari, Waleed L.
Saudi Arabia, Jeddah
International Medical Center
Grueneberger, J. M.
Germany, Freiburg Im Breisgau
Universität Freiburg
Statistics
Citations: 50
Authors: 10
Affiliations: 3
Identifiers
Doi:
10.1155/2011/765473
ISSN:
20900708
e-ISSN:
20900716
Research Areas
Noncommunicable Diseases